Literature DB >> 25312206

Emerging roles of P2X receptors in cancer.

Elena Adinolfi, Marina Capece, Francesca Amoroso, Elena De Marchi, Alessia Franceschini1.   

Abstract

Tumor microenvironment composition strongly conditions cancer growth and progression, acting not only at cancer itself but also modifying its interactions with immune, endothelial and nervous cells. Extracellular ATP and its receptors recently gained increasing attention in the oncological field. ATP accumulates in cancer milieu through spontaneous release, tumor necrosis or chemotherapy exerting a trophic activity on cancer cells, modulating the cross talk among tumor, and surrounding tissues. Accordingly, ATP gated P2X receptors emerged as central players in tumor development, invasion, progression and related symptoms. Indeed, P2X receptors are expressed and are functional not only on tumor cells but also in immune-infiltrate and nearby neurons. In this review, we summarize recent findings on P2X receptors role in tumor cell differentiation, bioenergetics, angiogenesis, metastasis and associated pain, giving an outline of the potential anti-neoplastic activity of receptor agonists and antagonists.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25312206     DOI: 10.2174/0929867321666141012172913

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  24 in total

1.  The Dynamic Behavior of the P2X4 Ion Channel in the Closed Conformation.

Authors:  Gustavo Pierdominici-Sottile; Luciano Moffatt; Juliana Palma
Journal:  Biophys J       Date:  2016-12-20       Impact factor: 4.033

2.  Epigenetic alteration of the purinergic type 7 receptor in salivary epithelial cells.

Authors:  Yong-Hwan Shin; Minkyoung Kim; Nahyun Kim; Seul-Ki Choi; Eun Namkoong; Se-Young Choi; Jong-Ho Lee; Seunghee Cha; Kyungpyo Park
Journal:  Biochem Biophys Res Commun       Date:  2015-09-21       Impact factor: 3.575

3.  P2x4 receptor promotes mammary cancer progression by sustaining autophagy and associated mesenchymal transition.

Authors:  Ruth Murrell-Lagnado; Sébastien Roger; Stéphanie Chadet; Jordan Allard; Lucie Brisson; Osbaldo Lopez-Charcas; Roxane Lemoine; Audrey Heraud; Stéphanie Lerondel; Roseline Guibon; Gaëlle Fromont; Alain Le Pape; Denis Angoulvant; Lin-Hua Jiang
Journal:  Oncogene       Date:  2022-04-11       Impact factor: 9.867

4.  2',3'-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents.

Authors:  Diego Dal Ben; Anna Marchenkova; Ajiroghene Thomas; Catia Lambertucci; Andrea Spinaci; Gabriella Marucci; Andrea Nistri; Rosaria Volpini
Journal:  Purinergic Signal       Date:  2016-10-18       Impact factor: 3.765

Review 5.  Mechanosensitive Ion Channels: TRPV4 and P2X7 in Disseminating Cancer Cells.

Authors:  Jacob M Hope; Joshua D Greenlee; Michael R King
Journal:  Cancer J       Date:  2018 Mar/Apr       Impact factor: 3.360

Review 6.  Metabolic crosstalk in the tumor microenvironment regulates antitumor immunosuppression and immunotherapy resisitance.

Authors:  Fang Wei; Dan Wang; Junyuan Wei; Niwen Tang; Le Tang; Fang Xiong; Can Guo; Ming Zhou; Xiaoling Li; Guiyuan Li; Wei Xiong; Shanshan Zhang; Zhaoyang Zeng
Journal:  Cell Mol Life Sci       Date:  2020-07-11       Impact factor: 9.261

Review 7.  Effect of P2X purinergic receptors in tumor progression and as a potential target for anti-tumor therapy.

Authors:  Wen-Jun Zhang
Journal:  Purinergic Signal       Date:  2021-01-09       Impact factor: 3.765

Review 8.  P2X7 receptor: a critical regulator and potential target for breast cancer.

Authors:  Xiaodi Zhu; Qianqian Li; Wei Song; Xiaoxiang Peng; Ronglan Zhao
Journal:  J Mol Med (Berl)       Date:  2021-01-23       Impact factor: 4.599

Review 9.  P2X Receptors: Potential Therapeutic Targets for Symptoms Associated With Lung Cancer - A Mini Review.

Authors:  Yonglin Mai; Zhihua Guo; Weiqiang Yin; Nanshan Zhong; Peter V Dicpinigaitis; Ruchong Chen
Journal:  Front Oncol       Date:  2021-06-29       Impact factor: 6.244

10.  The role of genetic polymorphisms in endolysosomal ion channels TPC2 and P2RX4 in cancer pathogenesis, prognosis, and diagnosis: a genetic association in the UK Biobank.

Authors:  Abeer F Alharbi; John Parrington
Journal:  NPJ Genom Med       Date:  2021-07-12       Impact factor: 8.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.